过敏性气喘治疗药市场:各药物类型,各给药途径,各地区-2023年~2030年的市场规模,占有率,展望,机会分析
市场调查报告书
商品编码
1330271

过敏性气喘治疗药市场:各药物类型,各给药途径,各地区-2023年~2030年的市场规模,占有率,展望,机会分析

Allergic Asthma Therapeutics Market, By Drug Type, By Route of Administration, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: | 出版商: Coherent Market Insights | 英文 220 Pages | 商品交期: 2-3个工作天内

价格
简介目录

过敏性气喘,也称为过敏性气喘,是一种慢性发炎性疾病。过敏性气喘是一种呼吸道疾病,当吸入过敏原时,呼吸的呼吸道会变窄。过敏性气喘是指某人吸入过敏原后出现呼吸困难。当过敏反应促使气道肿胀时就会发生这种情况。常见的过敏原包括花粉、皮屑和霉菌孢子。这种类型的气喘在儿童和成人中很常见。过敏性气喘的症状包括呼吸急促、咳嗽、喘息、鼻塞、眼睛发痒和皮疹。气喘是一种长期发炎性肺部疾病,由环境和遗传影响促使的发炎和气道狭窄引起。空气污染、气溶胶清洁产品、香烟烟雾、木材火灾和强烈气味等刺激性物质不会引起过敏反应。然而,它会刺激气道并加重气喘症状。气喘发作的特征是气道周围的肌肉收紧(支气管收缩),气道变窄,促使呼吸困难。呼吸系统疾病盛行率的上升和主要参与者的策略扩张预计将在预测期内推动全球过敏性气喘药物市场的成长。

市场动态

呼吸系统疾病盛行率的增加和对具有成本效益的治疗的需求不断增长预计将在预测期内推动全球过敏性气喘药物市场的成长。此外,污染水平上升和慢性阻塞性肺病(COPD)病例迅速增加也是推动市场成长的因素。例如,2023年3月16日,根据世界卫生组织(WHO)的数据,慢性阻塞性肺病(COPD)是全球第三大死因,2020年促使323万人死亡。

本调查的主要特征

  • 本报告提供以2022年为基准年的预测期间(2023-2030 年)之全球过敏性气喘治疗药市场的市场规模和復合年增长率(CAGR %)相关的详区隔析。
  • 并阐明不同部门市场的潜在收入机会,说明该市场具有魅力的投资主张矩阵。
  • 同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
  • 并基于企业亮点,各类型投资组合、主要焦点、财务业绩和市场策略等参数,介绍全球过敏性气喘治疗药市场的主要参与者之企业简介。
  • 藉由该报告提供的洞察,将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
  • 全球过敏性气喘治疗药市场报告配合该行业的各种利益相关者,包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
  • 利益相关者可以透过全球过敏性气喘治疗药市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

目录

第1章 调查目的与前提条件

  • 调查目的
  • 前提条件
  • 简称

第2章 市场概况

  • 报告概要
    • 市场定义和范围
  • 摘要整理
  • Coherent Opportunity Map(COM)

第3章 市场动态,法规,趋势分析

  • 市场动态
    • 促进因素
    • 阻碍因素
    • 市场魅力分析
    • 市场机会
    • 合併,收购,联盟
    • 与资金筹措投资
    • 未来展望
    • 法规指南和遵守
    • 主要的发展
    • PEST分析
    • 波特五力分析

第4章 全球过敏性气喘治疗药市场-COVID-19影响分析

  • 经济影响
  • COVID-19流行病学
  • 供需的影响

第5章 过敏性气喘治疗药的全球市场:各药物类型,2018年-2030年

  • 皮质类固醇药
  • 支气管扩张药
  • 白三烯调节药
  • 免疫疗法
  • 生技药品
  • 其他

第6章 过敏性气喘治疗药的全球市场:各给药途径,2018-2030年

  • 口服
  • 吸入
  • 其他

第7章 过敏性气喘治疗药的全球市场:各地区,2018年~2030年

  • 北美
  • 美国
  • 加拿大
  • 南美
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他南美国家
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 中东
  • GCC
  • 以色列
  • 其他中东
  • 非洲
  • 北非
  • 中非
  • 南非

第8章 竞争情形

  • ASLAN Pharmaceuticals
  • Takeda Pharmaceutical Company Limited
  • CHIESI Farmaceutici S.p.A.
  • CSL
  • NIOX
  • Fountain Therapeutics
  • Eli Lilly and Company
  • GSK plc.
  • Infinity Pharmaceuticals, Inc.
  • Mabtech
  • Kineta Inc.
  • Marinomed Biotech AG
  • Mycenax Biotech Inc.
  • AstraZeneca
  • Panacea Biotec

第9章 章节

  • 调查手法
  • 关于出版社
简介目录
Product Code: CMI4019

Allergic asthma, also known as allergy-induced asthma, is a chronic inflammatory condition Allergic asthma is a breathing condition where the airways you breathe through tighten when someone inhale an allergen. Allergic asthma is when someone develop breathing difficulties from inhaling allergens. It occurs when the airways swell as part of an allergic reaction. Common allergens include pollen, dander and mold spores. This type of asthma is very common in both children and adults. Symptoms of allergic asthma can include shortness of breath, coughing, wheezing, stuffy nose, itchy eyes and a rash. Asthma is a long-term inflammatory lung disease which is caused by inflammation and narrowing in the air passage resulting from environmental and genetic influences. Irritants such as air pollution, aerosol cleaning products, tobacco smoke, wood fires, and strong odors don't cause an allergic reaction. But they may inflame your airways and make asthma symptoms worse. An asthma attack is characterized by tightening of the muscles around the airways (bronchoconstriction), which narrows the airway and makes breathing difficult. The rising incidence of respiratory diseases and the strategic expansions by the key players are expected to propel the growth of global allergic asthma therapeutics market over the forecast period.

Market Dynamics

The rising incidence of respiratory diseases and the growing demand for cost-effective treatments are expected to propel the global allergic asthma therapeutics market growth over the forecast period. Additionally, an increase in pollution levels and an upsurge in cases of chronic obstructive pulmonary diseases (COPD) are other factors boosting the market growth. For instance, on March 16, 2023, according to the World Health Organization (WHO), Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2020.

Key features of the study:

  • This report provides in-depth analysis of the global allergic asthma therapeutics market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global allergic asthma therapeutics market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study are ASLAN Pharmaceuticals, Takeda Pharmaceutical Company Limited, CHIESI Farmaceutici S.p.A., CSL, NIOX, Fountain Therapeutics, Eli Lilly and Company, GSK plc., Infinity Pharmaceuticals, Inc., Mabtech, Kineta Inc., Marinomed Biotech AG, Mycenax Biotech Inc., AstraZeneca, and Panacea Biotec.
  • Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global allergic asthma therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergic asthma therapeutics market

Detailed Segmentation:

  • Global Allergic Asthma Therapeutics Market, By Drug Type:
    • Corticosteroids
    • Bronchodilators
    • Leukotriene modifiers
    • Immunotherapy
    • Biologics
    • Others
  • Global Allergic Asthma Therapeutics Market By Route of Administration:
    • Oral
    • Inhaled
    • Others
  • Global Allergic Asthma Therapeutics Market, By Region:
    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • ASLAN Pharmaceuticals
    • Takeda Pharmaceutical Company Limited
    • CHIESI Farmaceutici S.p.A.
    • CSL
    • NIOX
    • Fountain Therapeutics
    • Eli Lilly and Company
    • GSK plc.
    • Infinity Pharmaceuticals, Inc.
    • Mabtech
    • Kineta Inc.
    • Marinomed Biotech AG
    • Mycenax Biotech, Inc.
    • AstraZeneca
    • Panacea Biotec

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Drug Type
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Attractiveness Analysis
    • Market Opportunities
    • Merger, Acquisition, Collaborations
    • Funding and Investment
    • Future Prospective
    • Regulatory Guideline and Compliances
    • Key Developments
    • PEST Analysis
    • PORTER's Analysis

4. Global Allergic Asthma Therapeutics Market- COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Allergic Asthma Therapeutics Market, By Drug Type, 2018-2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Corticosteroids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Bronchodilators
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Leukotriene modifiers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Immunotherapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Biologics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

6. Global Allergic Asthma Therapeutics Market, By Route of Administration, 2018-2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segments Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Inhaled
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

7. Global Allergic Asthma Therapeutics Market, By Region, 2018-2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2018-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Billion)
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape

  • ASLAN Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Takeda Pharmaceutical Company Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • CHIESI Farmaceutici S.p.A.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • CSL
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • NIOX
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Fountain Therapeutics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eli Lilly and Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • GSK plc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Infinity Pharmaceuticals, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Mabtech
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Kineta Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Marinomed Biotech AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Mycenax Biotech Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • AstraZeneca
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Panacea Biotec
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Section

  • Research Methodology
  • About Us